Bank Of America Corp Obs Eva Sa Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.14 - $0.21 $61 - $91	438 Added 89.02%	930 $0
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.83 $74,956 - $979,782	-535,400 Reduced 99.91%	492 $0
Q2 2022 Aug 12, 2022	BUY	$1.34 - $2.08 $69,022 - $107,138	51,509 Added 10.63%	535,892 $862,000
Q1 2022 May 16, 2022	BUY	$1.1 - $2.17 $531,839 - $1.05 Million	483,490 Added 54142.22%	484,383 $731,000
Q4 2021 Feb 08, 2022	SELL	$1.99 - $3.1 $192,090 - $299,236	-96,528 Reduced 99.08%	893 $2,000

Q3 2021 Nov 15, 2021	BUY	$2.47 - $3.34 $233,343 - $315,533	94,471 Added 3202.41%	97,421 $303,000
Q2 2021 Sep 13, 2021	BUY	$2.56 - $3.35 $7,552 - $9,882	2,950 New	2,950 $9,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.